Bridgeway Capital Management’s Innovid Corp. CTV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-118,529
Closed -$366K 1276
2024
Q4
$366K Sell
118,529
-454,500
-79% -$1.07M 0.01% 879
2024
Q3
$1.03M Buy
573,029
+16,200
+3% +$29.4K 0.02% 677
2024
Q2
$1.03M Buy
556,829
+12,200
+2% +$26.2K 0.02% 671
2024
Q1
$1.36M Buy
544,629
+68,429
+14% +$118K 0.03% 662
2023
Q4
$714K Buy
476,200
+81,000
+20% +$103K 0.02% 845
2023
Q3
$506K Buy
395,200
+45,200
+13% +$52.9K 0.01% 867
2023
Q2
$382K Buy
+350,000
New +$363K 0.01% 980

Bridgeway Capital Management's CTV Position: Q1 2025 in Review

Bridgeway Capital Management sold out of Innovid Corp. (CTV) in Q1 2025, closing a stake of 118,529 shares — an estimated $366K sold.

Bridgeway Capital Management first reported a position in CTV in Q2 2023 and held it in 7 quarters. The position peaked at $1.36M in Q1 2024. 0 funds tracked by Wall St. Rank hold CTV as of Q1 2025.

  • Bridgeway Capital Management reported no remaining Innovid Corp. position as of Q1 2025 after selling out during the quarter.
  • Bridgeway Capital Management sold 118,529 Innovid Corp. shares in Q1 2025, an estimated $366K.
  • Bridgeway Capital Management first reported a position in Innovid Corp. in Q2 2023 and held it in 7 quarters.
  • Bridgeway Capital Management's Innovid Corp. position peaked at $1.36M in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Innovid Corp. as of Q1 2025.

Based on Bridgeway Capital Management's 13F filing for Q1 2025, filed 15 May 2025.